November 8-10, 2021 | Virtual Conference

Register Now en English


Hillel Cohen, PhD

Executive Director, Scientific Affairs
Sandoz, Inc

Dr. Hillel P. Cohen PhD is Executive Director of Scientific Affairs at Sandoz, helping explain the principles of biosimilars and biosimilar policies to the healthcare community, patient advocacy groups, and health authorities. He has published and given presentations in the areas of biosimilar education, switching, interchangeability, naming and safety. Dr. Cohen led Sandoz efforts for the first biosimilar presentation (Zarxio®) to an FDA advisory committee and participated in both BsUFA 2 and BsUFA 3 negotiations on behalf of industry. Hillel is active on the Education Committees of biosimilar trade associations, including the Biosimilars Council (a division of the Association for Affordable Medicines) and the Biosimilars Forum. Prior to joining Sandoz he held multiple positions at Novartis Vaccines, including Head of Regulatory Affairs for North and Latin America and well as Head of Global Labeling. Dr. Cohen received a BA from New York University and a PhD in Biology from Dartmouth.

Get Started & Register

Whether you are an AAM member, general attendee, or exhibitor, come meet the leaders and decision-makers who are determining the future of generics and biosimilars.

Register Now

Skip to content